Table 1.
Clinicopathologic characteristics of RCC patients by gankyrin expression in cohort 1 (n = 112).
Characteristic | Gankyrin |
Sum (112) | P value | |
---|---|---|---|---|
Low expression(n = 76) | High expression(n = 36) | |||
Age | 0.848 | |||
<60 | 45 | 22 | 67 | |
≥60 | 31 | 14 | 45 | |
Gender | 0.898 | |||
Male | 54 | 26 | 80 | |
Female | 22 | 10 | 32 | |
Fuhrman | 0.061 | |||
1 | 16 | 2 | 18 | |
2 | 38 | 18 | 56 | |
3 | 18 | 10 | 28 | |
4 | 4 | 6 | 10 | |
TNM stage | 0.001 | |||
1–2 | 71 | 25 | 96 | |
3 | 5 | 11 | 16 | |
SSIGN | <0.001 | |||
1–4 | 76 | 25 | 101 | |
≥5 | 0 | 11 | 11 | |
Overall survival | <0.001 | |||
− | 73 | 24 | 97 | |
+ | 3 | 12 | 15 | |
Progression free survival | 0.001 | |||
− | 73 | 27 | 100 | |
+ | 3 | 9 | 12 |
Statistical significance was calculated by chi-square test or fisher's exact test for categorical/binary measures and ANOVA for continuous measures.